Some results have been hidden because they may be inaccessible to you.Show inaccessible results
NMOSD treatment | -- | Terminal complement inhibition
SponsoredFDA-approved treatment for anti-AQP4 antibody-positive NMOSD. Efficacy data, safety and tolerability, dosing schedule, and vaccination requirements.REMS Program · HCP Resources · Safety · Weight-based Dosing


Feedback